Induced Mesenchymal Stem Cells: A New Frontier in Ovarian Cancer Treatment
Ovarian cancer urgently needs bold, transformative treatment approaches – not just small, incremental improvements. Synthetic,…
Induced Mesenchymal Stem Cells: A New Frontier in Ovarian Cancer Treatment
Ovarian cancer urgently needs bold, transformative treatment approaches – not just small, incremental improvements. Synthetic, allogeneic iMSCs as tumor-targeting delivery vehicles are an example of how cell biology and engineering may unite and overcome longstanding oncology challenges. The post Induced Mesenchymal Stem Cells: A New Frontier in Ovarian Cancer Treatment appeared first on MedCity News.
I Didn’t Dedicate My Career to Medicine to Manage Paperwork — And AI Scribes Won’t Fix That
What clinicians really need today is comprehensive support to offload routine tasks. They need intelligent systems that can proactively highlight relevant patient history before appointments, flag care gaps, and automatically queue up appropriate screening reminders or preventive care protocols. The post I Didn’t Dedicate My Career to Medicine to Manage Paperwork — And AI Scribes…
The Role of Claims Data Management to Support Evidence-Based Healthcare
[Sponsored] In an interview, Will Barnett, Veradigm Senior Solutions Manager, talked about the health tech vendor’s clearinghouse services and how they manage the relationship between payers and providers in support of evidence-based care and value-based care strategies. The post The Role of Claims Data Management to Support Evidence-Based Healthcare appeared first on MedCity News.
Where Jobs Are Scarce, Over 1 Million People Could Dodge Trump’s Medicaid Work Rules
Millions of Medicaid enrollees may have a way out of the new federal work requirement — if they live in a county with high unemployment. By January 2027, President Donald Trump’s far-reaching domestic policy law will require many adult, nondisabled Medicaid enrollees in 42 states and Washington, D.C., to work or volunteer 80 hours a…
In Hepatitis B Vaccine Debate, CDC Panel Sidesteps Key Exposure Risk
The Trump administration is continuing its push to revise federal guidelines to delay the hepatitis B vaccine newborn dose for most children. This comes despite a failed attempt to do so at the most recent meeting of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices. Both President Donald Trump and some…
States Target Ultraprocessed Foods in Bipartisan Push
California Republican James Gallagher, the GOP’s former Assembly leader, has often accused the state’s progressive lawmakers of heavy-handed government intrusion, but this year he added his name to a legislative push for healthier school meals. His party followed suit, with all but one Republican voting to send a bill to Democratic Gov. Gavin Newsom that…
A Look at the Potential Impact of the High Unemployment Hardship Exception to Medicaid Work Requirements
This issue brief describes the hardship exception for individuals living in counties with high unemployment, and using the most recent available county-level unemployment data, estimates the number of counties that could meet the criteria for this exception and the number of expansion enrollees living in those counties who could be exempt from work requirements.
Why Cedars-Sinai Is Rolling Out Regard’s Documentation Platform
Cedars-Sinai is rolling out Regard’s documentation platform to help hospital physicians manage complex patient charts. The tool synthesizes data, surfaces potential missed diagnoses and drafts clinical notes — all with the goals of decreasing administrative burden and allowing physicians to focus more on their patients. The post Why Cedars-Sinai Is Rolling Out Regard’s Documentation Platform…
Sanofi Pumps $625M Into Venture Arm to Back Breakthroughs in Early-Stage Startups
With the new capital infusion, Sanofi Ventures’ total assets under management now tops $1.4 billion. Our recap of other financings includes startups raising money for novel therapies in development for autoimmune disease, neurological disorders, cancer, and more. The post Sanofi Pumps $625M Into Venture Arm to Back Breakthroughs in Early-Stage Startups appeared first on MedCity…
Thyme Care Banks $97M to Accelerate Value-Based Cancer Care
Thyme Care’s Series D round included participation from CVS Health Ventures, Foresite Capital, Morgan Health and Humana. In total, it has raised $275 million. The post Thyme Care Banks $97M to Accelerate Value-Based Cancer Care appeared first on MedCity News.
